Position in KPTI
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,085,232
+$77,315 QoQ
Shares Held
733,435
+34.7% QoQ
Ownership
3.23%
of shares outstanding
% of Portfolio
0.66%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KPTI Over Time
Shares Held
Position Value (USD)
Derivatives in KPTI
reported options exposure · as of Mar 31, 2026CallValue
$5,124,400
CallShares
920,000
PutValue
$5,124,400
PutShares
920,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ikarian Capital, LLC holds $559,861,982 across 103 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
328,635 | $43,793,900 | |
| 2 | KOD |
Kodiak Sciences Inc.
|
1,059,730 | $41,287,080 | |
| 3 | ALMS |
Alumis Inc.
|
870,548 | $24,497,220 | |
| 4 | PRAX |
Praxis Precision Medicines, Inc.
|
72,842 | $24,386,773 | |
| 5 | PCVX |
Vaxcyte, Inc.
|
388,682 | $22,594,084 | |
| 6 | CLDX |
Celldex Therapeutics, Inc.
|
478,500 | $17,804,985 | |
| 7 | RCUS |
Arcus Biosciences, Inc.
|
504,559 | $15,555,553 | |
| 8 | RLMD |
Relmada Therapeutics, Inc.
|
2,148,359 | $14,866,644 |
All Filings in KPTI
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,124,400 | 920,000 | Put | Sole | 2026-05-15 | |
| 2026-03-31 | $5,124,400 | 920,000 | Call | Sole | 2026-05-15 | |
| 2026-03-31 | $4,085,232 | 733,435 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,007,917 | 544,554 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $178,260 | 27,257 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $117,477 | 27,257 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $101,941 | 27,257 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $276,415 | 408,899 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $339,764 | 409,355 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $355,320 | 409,355 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $618,126 | 409,355 | Shares | Sole | 2024-05-17 | |
| 2023-12-31 | $346,000 | 400,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $536,000 | 400,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $716,000 | 400,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,167,000 | 300,000 | Shares | Sole | 2023-05-15 | |
| 2022-03-31 | $6,117 | 830 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $5,047 | 785 | Shares | Sole | 2022-02-14 | |
| 2021-03-31 | $8,321 | 791 | Shares | Sole | 2021-08-18 | |
| 2020-12-31 | $12,244 | 791 | Shares | Sole | 2021-02-12 | |
| 2020-03-31 | $699,666 | 36,422 | Shares | Sole | 2020-05-15 | |
| 2020-03-31 | $10,600,078 | 551,800 | Put | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||